EX-99.1 4 brhc10046677_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1
 Preliminary Q4’22 & FY’22 Recap January 13, 2023 
 

 Disclaimer  2  This presentation contains highly confidential information and is solely for informational purposes. You should not rely upon or use it to form the definitive basis for any decision or action whatsoever, with respect to any proposed transaction or otherwise. You and your affiliates and agents must hold this presentation and any oral information provided in connection with this presentation, as well as any information derived by you from the information contained herein, in strict confidence and may not communicate, reproduce or disclose it to any other person, or refer to it publicly, in whole or in part at any time except with our prior written consent. If you are not the intended recipient of this presentation, please delete and destroy all copies immediately.   This presentation is “as is” and is based, in part, on information obtained from other sources. Our use of such information does not imply that we have independently verified or necessarily agree with any of such information, and we have assumed and relied upon the accuracy and completeness of such information for purposes of this presentation. Neither we nor any of our affiliates or agents, make any representation or warranty, express or implied, in relation to the accuracy or completeness of the information contained in this presentation or any oral information provided in connection herewith, or any data it generates and expressly disclaim any and all liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information or any errors or omissions therein. Any views or terms contained herein are preliminary, and are based on financial, economic, market and other conditions prevailing as of the date of this presentation and are subject to change. We undertake no obligations or responsibility to update any of the information contained in this presentation. Past performance does not guarantee or predict future performance.   This presentation contains Revlon, Inc.’s (the “Company”) preliminary estimates of certain financial results for the three months ended December 31, 2022 and the fiscal year ended December 31, 2022, based on currently available information. The Company has not yet finalized its results for these periods and its consolidated financial statements as of and for the year ended December 31, 2022 are not currently available. The Company's actual results remain subject to the completion of the year-end closing process, which includes review by management and the Company's board of directors, including the audit committee. While carrying out such procedures, the Company may identify items that require it to make adjustments to the preliminary estimates of its results set forth herein. As a result, the Company's actual results could be different from those set forth herein and the differences could be material. Additionally, the Company's estimates are forward-looking statements based solely on information available to it as of the date of hereof and may differ from actual results and such differences may be material. Therefore, a reader should not place undue reliance on these preliminary estimates of the Company's results. The preliminary estimates of the Company's results included herein have been prepared by, and are the responsibility of, the Company's management. The Company's independent auditors have not audited, reviewed or compiled such preliminary estimates of the Company's results. Accordingly, KPMG LLP expresses no opinion or any other form of assurance with respect thereto. The preliminary estimates of certain financial results presented herein should not be considered a substitute for the information to be filed with the Securities and Exchange Commission (the “SEC”) in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 once it becomes available.  This presentation contains certain non-GAAP financial measures which the Company uses as performance measures. These non-GAAP financial measures are reconciled herein to their respective most directly comparable GAAP measure. These non-GAAP financial measures should not be considered in isolation or as a substitute for their most directly comparable as reported measure prepared in accordance with GAAP and, along with the other information set forth herein, should be read in conjunction with the Company’s financial statements and related footnotes contained in documents filed with the SEC. Other companies may define such non-GAAP financial measures differently.   This presentation contains financial forecasts or projections (collectively, “Forecasts”) prepared by the Company. The Company’s independent registered public accounting firm has not audited, reviewed, compiled, or performed any procedures with respect to the Forecasts for the purpose of their inclusion in this presentation, and accordingly, the Company expresses no opinion or provides any other form of assurance with respect thereto for the purpose of this presentation. These Forecasts should not be relied upon as being necessarily indicative of future results. The Forecasts presented herein are provided solely for illustrative purposes, reflect the current beliefs of the Company as of the date hereof, and are based on a variety of assumptions and estimates which are subject to change. The Company assumes no obligation to update the Forecasts or information, data, models, facts or assumptions underlying the foregoing in this presentation.  This presentation does not constitute an offer to sell or the solicitation of an offer to buy any security, nor does it constitute an offer or commitment to lend, syndicate or arrange a financing, underwrite or purchase or act as an agent or advisor or in any other capacity with respect to any transaction, or commit capital, or to participate in any trading strategies, and does not constitute legal, regulatory, accounting or tax advice to the recipient. This presentation does not constitute and should not be considered as any form of financial opinion or recommendation by us or any of our affiliates. This presentation is not a research report nor should it be construed as such.  Cautionary Language Regarding Forward Looking Statements   This presentation includes “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “may,” “might,” “will,” “would,” “could,” “should,” “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward looking statements include estimated financial information. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which, unless otherwise indicated herein, speak only as of the date of this presentation. The Company does not commit to updating or revising the forward-looking statements set forth herein, whether as a result of new information, future events or otherwise, except as may be required by law.  
 

 Agenda  3  Preliminary FY’22 Results  Opening Remarks  Preliminary Q4’22  Preliminary H2’22   Preliminary FY’22  Normalized FY’22  FX Update 
 

 Opening Remarks   4  Summary Highlights:  Preliminary Q4’22 Net Sales in-line with the PF F8 forecast that was previously disclosed in the Company's Current Report on Form 8-K dated December 19, 2022 (“PF F8 Forecast”)   Preliminary Q4’22, H2’22, and FY’22 were all favorable to the PF F8 Forecast  Expense levels remain at favorable levels and continue to be managed closely to ensure efficiency  Focused brand support has contributed to continued US market share gains   While not yet fully recovered, post-filing efforts to stabilize and unlock the supply chain have led to improved production levels at manufacturing facilities and improved fill rates across key brands 
 

 Opening Remarks   5  Summary Challenges:  Despite supply chain improvements, certain brands are still being impacted by vendor specific constraints that are likely to continue into Q1’23 with efforts underway to alleviate  While the recent loosening of travel restrictions in China should have a positive overall impact on the long-term business plan, the recent and significant COVID-19 outbreaks in China are likely to be disruptive with respect to near-term results 
 

 Preliminary Q4’22 Bridges Relative to PF F8  6  Preliminary Q4’22 Gross Sales Relative to PF F8  (Unless otherwise noted, USD in millions at FY’22 Budget F/X Rates based on 6/30/21 spot)  Preliminary Q4’22 Recurring EBITDA Relative to PF F8  Gross sales for Q4 marginally unfavorable to FY’22 PF F8 (~1.7%)  Net sales for Q4 marginally unfavorable to FY’22 PF F8 (~0.6%) 
 
 Preliminary Q4’22 Bridges Relative to PF F8  6  Preliminary Q4’22 Gross Sales Relative to PF F8  (Unless otherwise noted, USD in millions at FY’22 Budget F/X Rates based on 6/30/21 spot)  Preliminary Q4’22 Recurring EBITDA Relative to PF F8  Gross sales for Q4 marginally unfavorable to FY’22 PF F8 (~1.7%)  Net sales for Q4 marginally unfavorable to FY’22 PF F8 (~0.6%) 
 

 Financials 
 

 Q4’22 Variance (at ’22 Budget FX Rates)  Preliminary Q4’22   8  (Unless otherwise noted, USD in millions at FY’22 Budget F/X Rates based on 6/30/21 spot) 
 

 H2’22 Variance (at ’22 Budget FX Rates)  Preliminary H2’22  9  (Unless otherwise noted, USD in millions at FY’22 Budget F/X Rates based on 6/30/21 spot) 
 

 FY’22 Variance (at ’22 Budget FX Rates)  Preliminary FY’22  10  Reflects FX adjustment from 2023 Budget FX Rates as of 6/30/22 to 9/30/22 Spot FX Rates  Adjusted Recurring EBITDA for FY22 PF F8 reflects reported FX rates for Jan’22 - Aug’22 and estimated spot rates for Sep’22 – Dec’22 (i.e., 8+4 forecast)  (Unless otherwise noted, USD in millions at FY’22 Budget F/X Rates based on 6/30/21 spot) 
 

 Normalized FY’22 
 

 Normalized 2022 Financial Profile  12  (1)  (1)  Source: Internal management projections  Projection as of mid-October Business Plan (forecast was published in the December 19, 2022 8-K)  Impact of OTIF discounts from unfulfilled orders  Adjustments for one-time true-up and reversal of activity relating to 2021 in returns, discounts & allowances and COGS  Reflects increased air freight costs incurred to ensure order fulfillment given supply chain challenges  Estimate of gross sales lost due to fill rate issues. Assumes the same Gross to Net % and Gross Contribution Margin % by brand as 2022 PF F8; Potential margin improvement from reduction of unabsorbed overhead has not been quantified in the adjustment above and would be incremental to the numbers presented herein  Assuming normalized supply chain operations and fill rates, management would expect Normalized PF F8 FY 2022 EBITDA to have been $299MM  (1)  (2)  (3)  (4)  (5)  (Unless otherwise noted, USD in millions at FY’23 Budget F/X Rates based on 6/30/22 spot) 
 

 Adjustments to 2022 PF F8  13  (1)  (1)  Adjustments to Pro Forma F8  (1) OTIF:  Impact of OTIF discounts from unfulfilled orders  (2) One-Time:   Adjustments for one-time true-up and reversal of activity relating to 2021 in returns, discounts & allowances and COGS  (3) Freight:  Reflects increased air freight costs incurred to ensure order fulfillment given supply chain challenges  (4) Fill Rates:  Estimate of gross sales lost due to fill rate issues  Projection as of mid-October Business Plan (forecast was published in the December 19, 2022 8-K)  Fill Rate adjustment assumes the same Gross to Net % and Gross Contribution Margin % by brand as 2022 PF F8; Potential margin improvement from reduction of unabsorbed overhead has not been quantified in the adjustment above and would be incremental to the numbers presented herein  Normalized 2022 PF F8 reflects adjustments to PF F8 2022 EBITDA; specific adjustments were made only for the items mentioned herein  (Unless otherwise noted, USD in millions at FY’23 Budget F/X Rates based on 6/30/22 spot) 
 

 FX Update 
 

 Preliminary FY’23 FX Update  15  (Unless otherwise noted, USD in millions at FY’23 Budget F/X Rates based on 6/30/22 spot)  Preliminary FX Change by Year  Revlon’s key non-USD currencies have materially strengthened against the USD from 9/30/22 to 12/31/22 resulting in an expected annual FX improvement of ~$22MM-$27MM through preliminary FY’26  The primary driver of the improvement was the Euro which strengthened 9.2% resulting in an expected annual ~$9MM improvement in preliminary FY’23 (increasing thereafter)  June 30th, 2022 spot rates   Transactional COGS FX impact quantified by local markets; represents risk from COGS purchasing in USD but selling in local currency (non-USD); a majority of Revlon's production occurs in the two United States facilities  FX Rate Variance (FC/USD)  Commentary  Preliminary FY’23 FX by Currency 
 

 Total Company: Non-GAAP Reconciliation   16  (USD in millions)  Reflects FX adjustment from 2023 Budget FX Rates as of 6/30/22 to 9/30/22 Spot FX Rates  Adjusted Recurring EBITDA for FY22 PF F8 reflects reported FX rates for Jan’22 - Aug’22 and estimated spot rates for Sep’22 – Dec’22 (i.e., 8+4 forecast)